Evolution of endothelial keratoplasty: Where are we headed?

Cornea

Volumn 34, Issue , 2015, Pages S41-S47

  Price, Francis W ^a   Feng, Matthew T ^a   Price, Marianne O ^b  

^a PRICE VISION GROUP   (United States)

^b Lautert)   (United States)

Author keywords

Aqueous shunts; Descemet membrane endothelial keratoplasty; Descemet stripping endothelial keratoplasty; DLEK; DMEK; DSAEK; DSEK; Glaucoma; Penetrating keratoplasty; Trabeculectomy

Indexed keywords

CORTICOSTEROID; FLUOROMETHOLONE; LOTEPREDNOL ETABONATE; PREDNISOLONE ACETATE; STEROID;

CORNEA; CORNEA TRANSPLANTATION; DEEP LAMELLAR ENDOTHELIAL KERATOPLASTY; DESCEMET MEMBRANE ENDOTHELIAL KERATOPLASTY; DESCEMET STRIPPING ENDOTHELIAL KERATOPLASTY; DISEASE EXACERBATION; EDEMA; ENDOTHELIAL KERATOPLASTY; FILTERING OPERATION; GLAUCOMA; GLAUCOMA DRAINAGE IMPLANT; GLAUCOMA SURGERY; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; INCIDENCE; OCULAR SURFACE DISEASE; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; RISK REDUCTION; UNITED STATES; VISION; VISUAL IMPAIRMENT; ADVERSE EFFECTS; PROCEDURES; TRENDS;

DESCEMET STRIPPING ENDOTHELIAL KERATOPLASTY; FILTERING SURGERY; GLAUCOMA DRAINAGE IMPLANTS; GRAFT REJECTION; HUMANS; RISK FACTORS;

EID: 84965130598     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0000000000000505     Document Type: Review

References (56)

1. Tillett CW. Posterior lamellar keratoplasty. Am J Ophthalmol. 1956;41:530-533.
2. Barraquer J, Rutlan J, eds. The technique for penetrating keratoplasty. In: Microsurgery of the Cornea. Barcelona, Spain: Scriba; 1984:289-294.
3. Jones DT, Culbertson WW. Endothelial lamellar keratoplasty (ELK). Invest Ophthalmol Vis Sci. 1998;39:876.
4. Melles GR, Eggink FA, Lander F, et al. A surgical technique for posterior lamellar keratoplasty. Cornea. 1998;17:618-626.
5. Melles GR, Wijdh RH, Nieuwendaal CP. A technique to excise the descemet membrane from a recipient cornea (descemetorhexis). Cornea. 2004;23:286-288.
6. Price FW Jr, Price MO. Descemet's stripping with endothelial keratoplasty in 50 eyes: a refractive neutral corneal transplant. J Refract Surg. 2005;21:339-345.
7. Melles GR, Lander F, Rietveld FJ. Transplantation of Descemet's membrane carrying viable endothelium through a small scleral incision. Cornea. 2002;21:415-418.
8. Gorovoy MS. Descemet-stripping automated endothelial keratoplasty. Cornea. 2006;25:886-889.
9. Price MO, Baig KM, Brubaker JW, et al. Randomized, prospective comparison of precut vs surgeon-dissected grafts for descemet stripping automated endothelial keratoplasty. Am J Ophthalmol. 2008;146:36-41.
10. Busin M, Bhatt PR, Scorcia V. A modified technique for descemet membrane stripping automated endothelial keratoplasty to minimize endothelial cell loss. Arch Ophthalmol. 2008;126:1133-1137.
11. Khor WB, Mehta JS, Tan DT. Descemet stripping automated endothelial keratoplasty with a graft insertion device: surgical technique and early clinical results. Am J Ophthalmol. 2011;151:223-232.e2.
12. Lie JT, Birbal R, Ham L, et al. Donor tissue preparation for Descemet membrane endothelial keratoplasty. J Cataract Refract Surg. 2008;34:1578-1583.
13. Tenkman LR, Price FW, Price MO. Descemet membrane endothelial keratoplasty donor preparation: navigating challenges and improving efficiency. Cornea. 2014;33:319-325.
14. Kruse FE, Lasser K, Cursiefen C, et al. A stepwise approach to donor preparation and insertion increases safety and outcome of Descemet Membrane Endothelial Keratoplasty (DMEK). Cornea. 2011;30:580-587.
15. Burkhart ZN, Feng MT, Price MO, et al. Handheld slit beam techniques to facilitate DMEK and DALK. Cornea. 2013;32:722-724.
16. Liarakos VS, Dapena I, Ham L, et al. Intraocular graft unfolding techniques in Descemet membrane endothelial keratoplasty. JAMA Ophthalmol. 2013;131:29-35.
17. Steven P, Le Blanc C, Velten K, et al. Optimizing Descemet membrane endothelial keratoplasty using intraoperative optical coherence tomography. JAMA Ophthalmol. 2013;131:1135-1142.
18. Stoeger C, Holiman J, Davis-Boozer D, et al. The endothelial safety of using a gentian violet dry-ink "S" stamp for precut corneal tissue. Cornea. 2012;31:801-803.
19. Okumura N, Kinoshita S, Koizumi N. Cell-based approach for treatment of corneal endothelial dysfunction. Cornea. 2014;33:S37-S41.
20. Koizumi N, Okumura N, Ueno M, et al. New therapeutic modality for corneal endothelial disease using Rho-associated kinase inhibitor eye drops. Cornea. 2014;33;S25-S31.
21. 2014 eye banking statistical Reports, available from the Eye Bank Association of America at. Available at: http://www.restoresight.org/wp-content/uploads/2014/04/2013-Statistical-Report-Order-Form.pdf. Accessed April 20, 2015.
22. Elder MJ, Stack RR. Globe rupture following penetrating keratoplasty: how often, why, and what can we do to prevent it? Cornea. 2004;23:776-780.
23. McKee Y, Price MO, Gunderson L, et al. Rapid sequential endothelial keratoplasty with and without combined cataract extraction. J Cataract Refract Surg. 2013;39:1372-1376.
24. Patel SV, Baratz KH, Maguire LJ, et al. Anterior corneal aberrations after Descemet's stripping endothelial keratoplasty for Fuchs' endothelial dystrophy. Ophthalmology. 2012;119:1522-1529.
25. Patel SV, McLaren JW. In vivo confocal microscopy of Fuchs endothelial dystrophy before and after endothelial keratoplasty. JAMA Ophthalmol. 2013;131:611-618.
26. Baydoun L, van Dijk K, Dapena I, et al. Repeat Descemet membrane endothelial keratoplasty after complicated primary Descemet membrane endothelial keratoplasty. Ophthalmology. 2015;122:8-16.
27. Cirkovic A, Schlotzer-Schrehardt U, Weller J, et al. Clinical and ultrastructural characteristics of graft failure in DMEK: 1-year results after repeat DMEK. Cornea. 2015;34:11-17.
28. Price MO, Feng MT, McKee Y, et al. Repeat Descemet membrane endothelial keratoplasty: secondary grafts with early intervention are comparable with fellow-eye primary grafts. Ophthalmology. 2015 Jun 5. pii: S0161-6420(15)00420-0. doi: 10.1016/j.ophtha.2015.04.037. [Epub ahead of print].
29. Yoeruek E, Bartz-Schmidt K. Secondary Descemet membrane endothelial keratoplasty after failed primary Descemet membrane endothelial keratoplasty: clinical results. Cornea. 2013;32:1414-1417.
30. Arbelaez JG, Price MO, Price FW Jr. Long-term follow-up and complications of stripping descemet membrane without placement of graft in eyes with Fuchs endothelial dystrophy. Cornea. 2014;33:1295-1299.
31. Thompson RW Jr, Price MO, Bowers PJ, et al. Long-term graft survival after penetrating keratoplasty. Ophthalmology. 2003;110:1396-1402.
32. Price MO, Fairchild KM, Price DA, et al. Descemet's stripping endothelial keratoplasty five-year graft survival and endothelial cell loss. Ophthalmology. 2011;118:725-729.
33. Anshu A, Price MO, Price FW. Descemet's stripping endothelial keratoplasty under failed penetrating keratoplasty: visual rehabilitation, complications and graft survival rate. Ophthalmology. 2011;118:2155-2160.
34. Williams KA, Roder D, Esterman A, et al. Factors predictive of corneal graft survival: report from the Australian corneal graft registry. Ophthalmology. 1992;99:403-414.
35. Anshu A, Price MO, Price FW Jr. Risk of corneal transplant rejection significantly reduced with Descemet's membrane endothelial keratoplasty. Ophthalmology. 2012;119:536-540.
36. Hjortdal J, Pedersen IB, Bak-Nielsen S, et al. Graft rejection and graft failure after penetrating keratoplasty or posterior lamellar keratoplasty for fuchs endothelial dystrophy. Cornea. 2013;32:e60-e63.
37. Li JY, Terry MA, Goshe J, et al. Graft rejection after Descemet's stripping automated endothelial keratoplasty: graft survival and endothelial cell loss. Ophthalmology. 2012;119:90-94.
38. Wu EI, Ritterband DC, Yu G, et al. Graft rejection following Descemet stripping automated endothelial keratoplasty: features, risk factors, and outcomes. Am J Ophthalmol. 2012;153:949-957.
39. Olson EA, Tu EY, Basti S. Stromal rejection following deep anterior lamellar keratoplasty: implications for postoperative care. Cornea. 2012;31:969-973.
40. Price MO, Price FW Jr, Kruse FE, et al. Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after Descemet membrane endothelial keratoplasty. Cornea. 2014;33:880-886.
41. Price MO, Feng MT, Sca1nameo A, et al. Loteprednol etabonate 0.5% gel vs. prednisolone acetate 1% solution after Descemet membrane endothelial keratoplasty: prospective, randomized trial. Cornea. 2015; May 26 [Epub ahead of print].
42. Price MO, Jordan CS, Moore G, et al. Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part two: the statistical analysis of probability and risk factors. Br J Ophthalmol. 2009;93:391-395.
43. Shimazaki J, Iseda A, Satake Y, et al. Efficacy and safety of long-term corticosteroid eye drops after penetrating keratoplasty: a prospective, randomized, clinical trial. Ophthalmology. 2012;119:668-673.
44. Nguyen NX, Seitz B, Martus P, et al. Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty. Am J Ophthalmol. 2007;144:318-319.
45. Vajaranant TS, Price MO, Price FW, et al. Visual acuity and intraocular pressure after Descemet's stripping endothelial keratoplasty in eyes with and without preexisting glaucoma. Ophthalmology. 2009;116:1644-1650.
46. Price MO, Thompson RW Jr, Price FW Jr. Risk factors for various causes of failure in initial corneal grafts. Arch Ophthalmol. 2003;121:1087-1092.
47. Sugar A, Tanner JP, Dontchev M, et al. Recipient risk factors for graft failure in the cornea donor study. Ophthalmology. 2009;116:1023-1028.
48. Anwar Z, Wellik SR, Galor A. Glaucoma therapy and ocular surface disease: current literature and recommendations. Curr Opin Ophthalmol. 2013;24:136-143.
49. Anshu A, Price MO, Price FW. Descemet's stripping endothelial keratoplasty: long-term graft survival and risk factors for failure in eyes with preexisting glaucoma. Ophthalmology. 2012:119:1982-1987.
50. Anshu A, Price MO, Price FW. Descemet's stripping endothelial keratoplasty under failed penetrating keratoplasty: visual rehabilitation and graft survival rate. Ophthalmology. 2011;118:2155-2160.
51. Aldave AJ, Chen JL, Zaman AS, et al. Outcomes after DSEK in 101 eyes with previous trabeculectomy and tube shunt implantation. Cornea. 2014;33:223-229.
52. Alvarado JA, Hollander DA, Juster RP, et al. Ahmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: long-term outcomes. Am J Ophthalmol. 2008;146:276-284.
53. Anshu A, Price MO, Richardson MR, et al. Alterations in the aqueous humor proteome in patients with a glaucoma shunt device. Mol Vis. 2011;17:1891-1900.
54. Ang LP, Higashihara H, Sotozono C, et al. Argon laser iridotomy-induced bullous keratopathy a growing problem in Japan. Br J Ophthalmol. 2007;91:1613-1615.
55. Lim LS, Ho CL, Ang LP, et al. Inferior corneal decompensation following laser peripheral iridotomy in the superior iris. Am J Ophthalmol. 2006;142:166-168.
56. Park HY, Lee NY, Park CK, et al. Long-term changes in endothelial cell counts after early phacoemulsification versus laser peripheral iridotomy using sequential argon:YAG laser technique in acute primary angle closure. Graefes Arch Clin Exp Ophthalmol. 2012;250:1673-1680.